← Leaderboards
Sheng Tong
University Of Kentucky
$2,577,964
Attributed
$2,577,964
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $533.5K · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,577,964 · 3
By mechanism
R01$1,999,057 · 1
R21$578,907 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Moriel Vandsburger$3,619,731
- Peter Nagy$2,674,240
- Ramkumar Tiruvannamalai Annamalai$991,759
Others in their field
Other Emerging Leaders on “Magnetism”
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Eric C Palm · Florida State University$35,115,872
- Michael W Rabin · Florida State University$26,502,247
- Ross D McDonald · Florida State University$26,502,247
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
Research focus
MagnetismClinical TranslationGenesMagnetic FieldDesignSpecificitySuccessPreclinical StudyMediatingVectorMagnetic NanoparticlesInsect VirusesMouse ModelNucleaseGuide RnaIn VivoGeneticGenotoxicityCrispr/Cas TechnologyDna SequenceClinical ApplicationImmunologicsClustered Regularly Interspaced Short Palindromic RepeatsViral Vector
Grant awards (8)
Precise in vivo gene editing of HSPC for the treatment of genetic hematologic diseases$191,250
R21 · FY2024 · HL · contact PI
Precise in vivo gene editing of HSPC for the treatment of genetic hematologic diseases$229,500
R21 · FY2023 · HL · contact PI
Magnetic nanocomplexes-induced immunomodulation for fracture healing$158,157
R21 · FY2023 · AR · contact PI
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors$494,605
R01 · FY2022 · EB · contact PI
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors$494,410
R01 · FY2021 · EB · contact PI
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors$307,164
R01 · FY2019 · EB · contact PI
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors$169,406
R01 · FY2019 · EB · contact PI
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors$533,472
R01 · FY2018 · EB · contact PI